What is Cytek Biosciences, Inc.'s other working capital?

Cytek Biosciences, Inc. (CTKB) reported other working capital of -$236K in Q1 2026.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Cytek Biosciences, Inc. CTKB Other Working Capital

Other Working Capital at other companies

Becton, Dickinson and CompanyBDX

-$48M-226%

Fulgent Genetics, Inc.FLGT

-$1K+95.2%

10x Genomics, Inc.TXG

-$193K+66.4%

TEC

Bio-TechneTECH

$1M+7.1%

Agilent TechnologiesA

$284M+51.9%

BrukerBRKR

-$11.8M-4.4%

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s other working capital?: Cytek Biosciences, Inc. (CTKB) reported other working capital of -$236K in Q1 2026.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.